Molecular epidemiology of norovirus GII.4 variants in children under 5 years with sporadic acute gastroenteritis in South Korea during 2006-2013
- Authors
- Cho, Han-Gil; Lee, Sung-Geun; Kim, Ju-Eun; Yu, Kyeong-Sin; Lee, Deog-Yong; Park, Po-Hyun; Yoon, Mi-hye; Jho, Eek-Hoon; Kim, Jaehong; Paik, Soon-Young
- Issue Date
- Nov-2014
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Viral gastroenteritis; Norovirus; Genogroup; GII.4 variant
- Citation
- JOURNAL OF CLINICAL VIROLOGY, v.61, no.3, pp.340 - 344
- Journal Title
- JOURNAL OF CLINICAL VIROLOGY
- Volume
- 61
- Number
- 3
- Start Page
- 340
- End Page
- 344
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12156
- DOI
- 10.1016/j.jcv.2014.08.018
- ISSN
- 1386-6532
- Abstract
- Background: The global emergence of norovirus (NoV) GII.4 variants has raised public concerns in the world including South Korea since 1996. Objective: We analyzed seasonality and genotypic pattern for sporadic cases by norovirus GII-4 variants. Study design: To determine the epidemic status of GII.4 variants in South Korea during 2006-2013, 7301 fecal specimens were collected from children who were younger than 5 years and had sporadic acute gastroenteritis (AGE). Results: During the study period, NoVs were the most prevalent viral agent, detected in 877 (12.0%) of the 7301 fecal specimens from children with sporadic AGE. NoV GII strains predominantly accounted for 97.6% of all sporadic NoV infections. NoV GII.4 was the most prevalent genotype and comprised 67.6% of the NoV GII strains. However, seasonal prevalence of GII. 4 strains varied depending on the spread of GII. 4 variants. GII.4-2006b variant most predominantly circulated from 2006-2007 to 2009-2010 and persisted during other seasons. GII.4-2009 variant was first detected in January 2010 and predominantin 2011-2012. However, it was rapidly displaced by GII.4-2012 variant, which emerged in May 2012 and substantially circulated in 2012-2013. Conclusions: The frequent emergence and rapid spread of GII. 4 variants significantly affect the magnitude of sporadic NoV infections in children. Hence, to minimize the disease burden of NoV infections, GII.4 strains should be considered as a primary target for vaccine development against NoVs. (C) 2014 Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12156)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.